Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Kaplan–Meier curves showed that extended adjuvant pyrotinib administered after trastuzumab-based adjuvant therapy provides a promising survival benefit in patients with high-risk HER2-positive breast ...

Yelena Y. Janjigian, MD, discusses the long-term survival data from the KEYNOTE-811 trial of pembrolizumab plus trastuzumab ...

Puma Biotechnology announced that inducement awards were granted to staff hired in March, 2025, in accordance with Nasdaq ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

A study in Science finds that linoleic acid, a fat found in seed oils and eggs, can activate the mTORC1 pathway, accelerating ...

Researchers are shedding new light on the link between diet and cancer growth—especially the way certain fats may fuel ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

IgG antibodies are commonly used in cancer treatment. They help the body's immune system fight cancer and are being ...

Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, an investigational oral inhibitor designed to target RAS ...

Tayla Gardiner, 32, discovered a lump in her breast while she was in the shower. She credits her cup-E breast implants for helping her find the lump. She was diagnosed with triple-negative breast ...